Pharma stocks and massive potential are synonymous. With horrible diseases like cancer, diabetes, and heart disease still a mile away from developing a cure, drugs that address these conditions command outrageous prices. Hence, any company creating a new drug to manage it and subsequently get FDA approval results in stock prices soaring faster than SpaceX’s Starship.
The industry is packed with potential opportunities for a high-returning portfolio. In this article, we have curated a list of three pharmaceutical stocks that could boost your portfolio for 2024.
This post appeared first on InvestorPlace.